Prognostic factors in ovarian adult granulosa cell tumour

Journal of Clinical Pathology

Volumn 61, Issue 8, 2008, Pages 881-884

  Miller, Keith ^a   McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; PROTEIN P53; TRANSCRIPTION FACTOR GATA 4;

AGING; ANEUPLOIDY; CANCER RECURRENCE; CANCER SURVIVAL; CELL NUCLEUS; CELL PROLIFERATION; DISEASE SEVERITY; FLOW CYTOMETRY; GENE MUTATION; GRANULOSA CELL TUMOR; HEMOPERITONEUM; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; MITOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VOLUME;

FEMALE; GRANULOSA CELL TUMOR; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLOIDIES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 49149095547     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2008.057604     Document Type: Review

References (39)

1. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary: a clinicopathological analysis of 125 cases. Am J Surg Pathol 1984;8:575-96.
2. Hines JF, Khalifa MA, Moore JL, et al. Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 1996;60:484-8.
3. Fox H. Pathologic prognostic factors in early stage adult-type granulosa cell tumors of the ovary. Int J Gynecol Cancer 2003;13:1-4.
4. Leuverink EM, Brennan BA, Crook ML, et al. Prognostic value of mitotic counts and Ki-67 immunoreactivity in adult-type granulosa cell tumour of the ovary. J Clin Pathol. Published Online First: 22 April 2008. doi:10.1136/jcp.2008.056093
5. Costa MJ, Walls J, Ames P, et al. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol 1996;27:274-81.
6. Fox H, Agrawal K, Langley FA. A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer 1975;35:231-41.
7. Norris HJ, Taylor HB. Prognosis of granulosa-theca tumors of the ovary. Cancer 1968;21:255-63.
8. Ohel G, Kaneti H, Schenker JG. Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol 1983;15:278-86.
9. Mehta H, Trivedi P, Parikh B, et al. Clinicopathological prognostic factors of adult granulosa cell tumor of the ovary - a study of 37 cases. Indian J Pathol Microbiol 2005;48:439-43.
10. Miller BE, Barron BA, Wan JY, et al. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 1997;79:1951-5.
11. Villella J, Herrmann FR, Kaul S, et al. Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. Int J Gynecol Pathol 2007;26:154-9.
12. Fontanelli R, Stefanon B, Raspagliesi F, et al. Adult granulosa cell tumor of the ovary: a clinico pathologic study of 35 cases. Tumori 1998;84:60-4.
13. Sehouli J, Drescher FS, Mustea A, et al. Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Res 2004;24:1223-9.
14. Lee WL, Yuan CC, Lai CR, et al. Hemoperitoneum is an initial presentation of recurrent granulosa cell tumors of the ovary. Jpn J Clin Oncol 1999;29:509-12.
15. Björkholm E, Silfverswärd C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol 1981:11:261-74.
16. Jurić G, Zarković N, Nola M, et al. The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori 2001;87:47-53.
17. Hitchcock CL, Norris HJ, Khalifa MA, et al. Flow cytometric analysis of granulosa tumors. Cancer 1989;64:2127-32.
18. Stenwig JT, Hazekamp JT, Beecham JB. Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 1979;7:136-52.
19. Vesco KK, Carney ME. Granulosa cell tumor of the ovary: extensive late recurrence after initial occult microscopic disease. Obstet Gynecol 2002;99:888-91.
20. Anttonen M, Unkila-Kallio L, Leminen A, et al. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors. J Clin Endocrinol Metab 2005;90:6529-35.
21. Lauszus FF, Petersen AC, Greisen J, et al. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage I disease. Gynecol Oncol 2001;81:456-60.
22. Malmström H, Högberg T, Risberg B, et al. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 1994;52:50-5.
23. Fujimoto T, Sakuragi N, Okuyama K, et al. Histopathological prognostic factors of adult granulosa cell tumors of the ovary. Acta Obstet Gynecol Scand 2001;80:1069-74.
24. Kusamura S, Derchain S, Alvarenga M, et al. Expression of p53, c-erbB-2, Ki-67, and CD34 in granulosa cell tumor of the ovary. Int J Gynecol Cancer 2003;13:450-7.
25. Haba R, Miki H, Kobayashi S, et al. Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor. Cancer 1993;72:3258-62.
26. Suh KS, Silverberg SG, Rhame JG, et al. Granulosa cell tumor of the ovary. Histopathologic and flow cytometric analysis with clinical correlation. Arch Pathol Lab Med 1990;114:496-501.
27. Miller BE, Barron BA, Dockter ME, et al. Parameters of differentiation and proliferation in adult granulosa cell tumors of the ovary. Cancer Detect Prev 2001;25:48-54.
28. King LA, Okagaki T, Gallup DG, et al. Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. Gynecol Oncol 1996;61:227-32.
29. Klemi PJ, Joensuu H, Salmi T. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary. Cancer 1990;65:1189-93.
30. Wabersich J, Fracas M, Mazzer S, et al. The value of the prognostic factors in ovarian granulosa cell tumors. Eur J Gynaecol Oncol 1998;19:69-72.
31. Young RH, Scully RE. Ovarian sex-cord-stromal tumors with bizarre nuclei: a clinicopathologic analysis of seventeen cases. Int J Gynecol Pathol 1983;1:325-35.
32. Ala-Fossi SL, Mäenpää J, Aine R, et al. Prognostic significance of p53 expression in ovarian granulosa cell tumors. Gynecol Oncol 1997;66:475-9.
33. Gebhart JB, Roche PC, Keeney GL, et al. Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecol Oncol 2000;77:232-6.
34. McCluggage WG, Oliva E, Connolly LE, et al. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 2004;23:330-6.
35. McCluggage WG, Connolly LE, McGregor G, et al. A strategy for defining biologically relevant levels of p53 protein expression in clinical samples with reference to endometrial neoplasia. Int J Gynecol Pathol 2005;24:307-12.
36. Evans MP, Webb MJ, Gaffey TA, et al. DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients. Cancer 1995 1;75:2295-8.
37. Staibano S, Franco R, Mezza E, et al. Loss of oestrogen receptor β, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours. Histopathology 2003;43:254-62.
38. Roush GR, el-Naggar AK, Abdul-Karim FW. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis. Gynecol Oncol 1995;56:430-4.
39. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003;21:1180-9.